iBio DSO Ratio 2011-2026 | IBIO

Annual DSO Ratio iBio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	138	38.6	1.25 K	17.5	61.7	162	233	87.7	365	365	100	241

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.25 K	17.5	255

Quarterly DSO Ratio iBio

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28.3	86.4	344	463	36.1	31.1	41.7	9.71	33.3	43.5	72.7	28.2	106	19.2	197	10.5	123	118	163	58.1	247	119	221	589	232	232	264	303	293	72.6	11.4	51	67.5	-	-	-	-	-	86.7	82.1	68.4	108	94.6	134	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
589	9.71	136

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Mesoblast Limited MESO	0.00568	$ 14.32	2.14 %	$ 9.29 B	Australia
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 215.54	-1.16 %	$ 5 B	Danmark
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.23	-	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.18	-2.97 %	$ 109 M	USA
MediciNova MNOV	365	$ 1.45	-	$ 71.1 M	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.71	17.15 %	$ 8.13 M	Israel
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Exelixis EXEL	43.4	$ 41.57	0.39 %	$ 11.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Genmab A/S GMAB	97.9	$ 25.81	0.51 %	$ 16.6 B	Danmark
Aytu BioScience AYTU	150	$ 2.65	0.76 %	$ 16.6 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
NovaBay Pharmaceuticals NBY	34.4	$ 1.5	11.94 %	$ 8.73 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.31	-2.49 %	$ 826 M	Canada
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Ionis Pharmaceuticals IONS	20.5	$ 69.68	-1.57 %	$ 11.1 B	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA